For example, among patients aged 50–59, the median PSA in patients with PCa was >4 ng/mL, whereas the 90th percentile of PSA in patients without PCa was <4 ng/mL (Figure S2). The gene discussed is KLK3; the disease is posterior cortical atrophy.